scholarly journals Surgical management for adventitial cystic disease of common femoral vein

Author(s):  
Jong Seok Lee ◽  
Sang Dong Kim
2018 ◽  
Vol 67 (6) ◽  
pp. e159
Author(s):  
Bryce French ◽  
Swee Lian Tan ◽  
Emily Kobayashi

2018 ◽  
Vol 27 (2) ◽  
pp. 312-313 ◽  
Author(s):  
Ayaka Iwasaki ◽  
Koji Furukawa ◽  
Eisaku Nakamura ◽  
Kunihide Nakamura

2016 ◽  
Vol 165 (1) ◽  
pp. 75 ◽  
Author(s):  
Sean O'Loghlen ◽  
Grayson J. Hall ◽  
Nadil Zeiadin ◽  
Laura Milne ◽  
Benedetto Mussari

2021 ◽  
Vol 50 (3) ◽  
pp. 207-209
Author(s):  
Kenji Matsuzaki ◽  
Ko Takigami ◽  
Hiroshi Matsuura

2013 ◽  
Vol 30 (1) ◽  
pp. 11-16 ◽  
Author(s):  
YueXin Chen ◽  
RuiXue Sun ◽  
Jiang Shao ◽  
YongJun Li ◽  
ChangWei Liu

Venous adventitial cystic disease is a rare vascular disease. The objective of the study is to contemporarily review the literature of venous adventitial cystic disease and report three other new cases of adventitial cystic disease in common femoral vein. Articles published between 1947 and April 2013 were searched in OVID and PubMed databases. The search yielded only 38 reported cases of venous adventitial cystic disease. The general characteristics and disease management information of the 41 cases (including our current 3 cases) were analyzed. Venous adventitial cystic disease could develop late in life with an average age of 48.39 years (range, 5 to 77 years). Similar to arterial adventitial cystic disease, venous adventitial cystic disease was also found to have a male predominance (male to female ratio, 1.28:1). The common femoral vein was the most likely vein to be involved (65.9%, 27 cases). Right and left sides were almost equally affected. Extremity swelling (86.8%, 33 cases) was the main symptom of patients presenting with venous adventitial cystic disease. Excision of cyst wall in 30 patients (73.2%) was the main surgical procedure with a recurrence rate of 11.5%. Thirteen involved veins were resected; of which, 10 were reconstructed with prosthetic or autologous graft. No recurrence was reported in these 13 patients. Postoperatively, nine cases received an anticoagulation therapy. In conclusion, the etiology, treatment strategy, and outcomes of venous adventitial cystic disease could not be well understood in the present review due to limited numbers of cases. Studies with careful follow-up for at least up to first several months are recommended.


2016 ◽  
Vol 39 (3) ◽  
pp. 178-181 ◽  
Author(s):  
Young-Kyun Kim ◽  
Ho Jong Chun ◽  
Jeong Kye Hwang ◽  
Ji Il Kim ◽  
Sang Dong Kim ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Corey Bascone ◽  
Mazen Iqbal ◽  
Patrick Narh-Martey ◽  
Mauricio Szuchmacher ◽  
Michael Cicchillo ◽  
...  

Purpose. To review and identify the most accurate ways of diagnosing and treating adventitial cystic disease (ACD) of the venous system. Methods. Cases of ACD were collected through three popular medical databases, including PubMed, Cochrane, OVID, and MEDLINE. After reviewing the literature, the sites of occurrence of 323 cases of adventitial cystic disease were documented, and all cases of arterial ACD were excluded. The clinical features, treatment, and subsequent course of 45 cases of venous ACD are included in this paper. Results. After reviewing all 45 cases of venous ACD , we have confirmed that the most common vessel affected is the common femoral vein, which reproduces the most common symptom of venous ACD: asymmetric lower extremity swelling worsening over time. Conclusion. Venous ACD most commonly affects the common femoral vein. When unilateral leg swelling occurs with or without a noticeable mass, ACD should be considered. It is best confirmed with CT venography and the treatment of choice is transluminal cyst evacuation and excision.


Sign in / Sign up

Export Citation Format

Share Document